title: [A trial of the use of the immunocorrective preparation Imunofan for treating diphtheria].
abstract: Peptide immunocorrector Imunofan was used as adjuvant to conventional treatment. A single intramuscular injection was given daily for 8-10 days (I ml of 0.005% solution). In patients with advanced and toxic diphtheria Imunofan reduced the occurrence of specific complications and lethality fell 4.1-4.8-fold. Imunofan is also recommended for patients with allergic reaction to diphtheria antitoxin.
authors.forename: V V
authors.initials: VV
authors.lastname: Lebedev
authors.forename: V A
authors.initials: VA
authors.lastname: Bolibok
authors.forename: V V
authors.initials: VV
authors.lastname: Borzunov
authors.forename: N V
authors.initials: NV
authors.lastname: Efimov
authors.forename: V Z
authors.initials: VZ
authors.lastname: Tenkachev
authors.forename: V I
authors.initials: VI
authors.lastname: Pokrovskiĭ
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D016009:Chi-Square Distribution; D003131:Combined Modality Therapy; D004165:Diphtheria / Q000188:drug therapy*; D004166:Diphtheria Antitoxin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*
chemical_list: D000276:Adjuvants, Immunologic; D004166:Diphtheria Antitoxin; D009842:Oligopeptides; C080035:thymohexin
vernacular_title: Opyt primeneniia immunokorrigiruiushchego preparata "Imunofan" dlia lecheniia difterii.